Bicycle Therapeutics Ltd
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 626.7% | 132.1% | 296.0% | 350.4% | 614.3% | 98.3% | 429.5% | 989.9% | 125.9% | 688.6% | 506.6% | 191.6% | 261.4% | 536.1% | 635.2% | 233.6% | 368.5% | 349.6% | 417.9% | 704.4% | 43.8% | 32.1% | 14.5% | 2,832.7% | 31.3% | 8.5% | 17.5% | 1,705.8% | 1,512.2% | 574.0% | 2,432.5% | – | 73.1% | – | – | – | |
| -526.7% | -32.1% | -196.0% | -250.4% | -514.3% | 1.7% | -329.5% | -889.9% | -25.9% | -588.6% | 100.0% | 100.0% | -161.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -1,605.8% | -1,412.2% | -474.0% | -2,332.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1,065.3% | 132.1% | 296.0% | 350.4% | 614.3% | 98.3% | 429.5% | 989.9% | 159.0% | 860.1% | 506.6% | 191.6% | 340.4% | 536.1% | 656.7% | 242.6% | 343.6% | 370.1% | 453.5% | 748.4% | 776.1% | 657.9% | 348.5% | 744.9% | 838.4% | 178.5% | 427.9% | 1,803.6% | 1,342.4% | 591.9% | 2,432.5% | 497.9% | 108.0% | 5,513.1% | 6,543.7% | 327.2% | |
| 392.4% | 70.8% | 102.5% | 144.4% | 199.2% | 53.3% | 195.3% | 780.0% | 64.3% | 442.7% | 400.6% | 166.7% | 282.0% | 447.8% | 411.5% | 190.8% | 231.3% | 436.4% | 254.5% | 337.1% | 336.4% | 286.7% | 133.2% | 290.9% | 282.3% | 84.2% | 171.5% | 682.2% | 566.9% | 211.7% | 658.8% | 162.1% | 43.5% | 1,981.4% | 2,230.2% | 116.8% | |
| 364.7% | 202.9% | 398.5% | 494.8% | 813.5% | 151.6% | 624.8% | 1,769.9% | 64.3% | 442.7% | 901.0% | 377.9% | 282.0% | 986.3% | 1,067.9% | 429.9% | 578.0% | 809.4% | 723.6% | 1,078.9% | 1,111.3% | 953.8% | 478.3% | 1,049.1% | 1,117.4% | 262.4% | 598.3% | 780.0% | 412.6% | 229.6% | 633.3% | 658.6% | 151.4% | 7,494.5% | 8,773.9% | 443.7% | |
| -919.1% | -102.9% | -298.5% | -394.8% | -713.5% | -51.6% | -524.8% | -1,669.9% | -90.2% | -1,031.3% | -801.0% | -277.9% | -443.3% | -886.3% | -967.9% | -329.9% | -478.0% | -709.4% | -623.6% | -978.9% | -1,011.3% | -853.8% | -378.3% | -949.1% | -1,017.4% | -162.4% | -498.3% | -2,385.9% | -1,824.8% | -703.7% | -2,965.8% | -558.6% | -51.4% | -7,394.5% | -8,673.9% | -343.7% | |
| 0.5% | 0.1% | – | – | 0.0% | 0.0% | – | – | – | 18.8% | 23.6% | 1.9% | 11.4% | 28.9% | 45.9% | 19.0% | 21.7% | 21.2% | 20.2% | 26.9% | 25.9% | 16.5% | 7.2% | 15.2% | 15.4% | 4.2% | 8.8% | 1.2% | 1.4% | 0.5% | 1.8% | 0.4% | 0.1% | 5.4% | 7.0% | 0.3% | |
| -887.9% | -104.3% | -299.8% | -477.8% | -628.3% | -100.6% | -662.4% | -1,598.2% | -86.0% | -1,012.5% | -777.3% | -276.0% | -454.5% | -914.3% | -1,012.5% | -348.3% | -498.1% | -724.9% | -623.0% | -940.3% | -954.4% | -810.5% | -378.3% | -889.9% | -915.0% | -137.8% | -424.1% | -2,027.3% | -1,428.0% | -619.8% | -2,711.7% | -501.9% | -39.4% | -6,838.0% | -7,987.8% | -308.3% | |
| 1.4% | -14.1% | -3.1% | -1.6% | -8.9% | 1.3% | 8.9% | -53.9% | -2.6% | -9.5% | -6.2% | -12.1% | -1.5% | -18.8% | -9.0% | -9.6% | -19.8% | -10.9% | -10.2% | -7.8% | -13.2% | -12.6% | -4.5% | 42.5% | 6.0% | -1.8% | 1.2% | -128.8% | -29.2% | -10.9% | -7.9% | 1.7% | 2.6% | 19.4% | 14.3% | 2.8% | |
| -889.3% | -90.2% | -299.8% | -477.8% | -628.3% | -101.9% | -671.3% | -1,544.3% | -83.4% | -1,003.0% | -771.2% | -263.9% | -453.0% | -895.5% | -1,003.5% | -338.7% | -478.3% | -714.1% | -612.8% | -932.5% | -941.2% | -797.9% | -373.8% | -932.3% | -921.0% | -136.0% | -425.3% | -1,898.4% | -1,398.4% | -608.9% | -2,703.8% | -503.7% | -42.0% | -6,857.4% | -8,002.1% | -311.1% | |
| -903.2% | -99.1% | -287.1% | -384.1% | -696.1% | -48.3% | -509.7% | -1,630.3% | -85.0% | -1,004.3% | -757.6% | -267.4% | -434.7% | -867.5% | -947.6% | -321.6% | -465.6% | -692.8% | -588.7% | -871.8% | -885.0% | -762.2% | -356.7% | -843.1% | -868.6% | -125.1% | -397.7% | -2,287.3% | -1,380.7% | -603.9% | -2,651.8% | -486.6% | -36.5% | -6,705.3% | -7,811.1% | -299.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.